Based on the detection of AFC (7-amino-4-trifluoromethyl coumarin) after cleavage from the labelled substrate LEHD-AFC.
Product Details
| Alternative Name: | ICE-LAP-6, Mch6 |
| |
| Applications: | Fluorescent detection
Activity assay
|
| |
| Handling: | Store Cell Lysis Buffer and 2X Reaction Buffer at 4°C after opening. Protect from light. |
| |
| Shipping: | Blue Ice |
| |
| Long Term Storage: | -20°C |
| |
| Contents: | 25ml Cell Lysis Buffer, 2ml 2X Reaction Buffer, 125µl LEHD-AFC Substrate (1mM), 100µl DTT (1M). |
| |
| Technical Info/Product Notes: | LEHD-AFC emits blue light (λmax = 400nm); upon cleavage of the substrate by caspase-9 or related caspases, free AFC emits a yellow-green fluorescence (λmax = 505nm), which can be quantified using a fluorometer or a fluorecence microtiter plate reader. Comparison of the fluorescence of AFC from an apoptotic sample with an uninduced control allows determination of the fold increase in caspase-9 activity.
Biocompare Article: Keep an Eye on Apoptosis with Caspase Assays |
| |
| UniProt ID: | P55211 |
| |
| Regulatory Status: | RUO - Research Use Only |
| |
Product Literature References
Stillage Waste from Strawberry Spirit Production as a Source of Bioactive Compounds with Antioxidant and Antiproliferative Potential: C. Spagnuolo, et al.; Antioxidants
12, 421 (2023),
Abstract;
Multifunctional thiosemicarbazones targeting sigma receptors: in vitro and in vivo antitumor activities in pancreatic cancer models: M. Niso, et al.; Cell. Oncol. (Dordr.)
44, 1307 (2021),
Abstract;
Cadmium nitrate-induced neuronal apoptosis is protected by N-acetyl-l-cysteine via reducing reactive oxygen species generation and mitochondria dysfunction: C.Y. Lee, et al.; Biomed. Pharmacother.
108, 448 (2018),
Abstract;
Caspase activation by a zinc-oxide eugenol-based root-canal sealer in cementoblasts: F.M. Huang, et al.; J. Dent. Sci. 10, 338 (2015), Application(s): Fluorometric Assay using murine cementoblasts ,
Synergistic anti-myeloma activity of the proteasome inhibitor marizomib and the IMiD immunomodulatory drug pomalidomide: D.S. Das, et al.; Br. J. Haematol.
171, 798 (2015),
Abstract;
Full Text
